pharmaphorum

JUNE 1, 2022

Astellas has become the latest big pharma company to sink some money into immuno-oncology start-up GO Therapeutics, forging an alliance to develop antibodies targeting two glycoprotein targets. The Japanese drugmaker is paying $20.5 The post Astellas taps GO’s glycoprotein platform with $783.5m deal appeared first on.

Gene Therapy 98

Gene Therapy Clinical Development Antibody Gene 98

pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 109

Radiology Marketing Genome Genomics 109

pharmaphorum

APRIL 12, 2022

Separating the amount of antibiotic used from the payment model could entice pharma companies – who have abandoned antimicrobial R&D in their drives in the last decades – to enter the category once again and help to develop new drugs that will tackle the pressing issue of antimicrobial resistance (AMR).

Pharma Companies 117

Pharma Companies Development Drugs Medicine 117

Drug Discovery World

OCTOBER 18, 2022

The Clinical Trials Environmental Impact Community of Interest (CoI) was started by Pistoia Alliance member, Syneos Health. The group will work closely with another member, the Sustainable Health Coalition (SHC), in support of its work with the Sustainable Markets Initiative (SMI). Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

OCTOBER 15, 2021

Pharma companies are embracing patient centricity in drug development more than ever before. Over the last decade, leaders in the industry have championed patient engagement, putting it at the heart of commercial strategies. I don’t want to be called a patient, and I’m not on a journey.”. “I

Pharma Companies 40

Pharma Companies Clinical Development Medicine Development 40

Delveinsight

AUGUST 2, 2020

The dynamics of the cancer cachexia market is expected to gain momentum as several companies are testing the waters, advancing cancer cachexia pipeline. Moreover, an increasing trend of the cancer cachexia prevalence during the forecast year is also a reason that has spurred pharma players to invest in the cancer cachexia market.

Marketing 94

Marketing Pharma Companies Development Hormones 94

XTalks

MARCH 28, 2024

The FDA’s approval of Duvyzat for DMD, based on our robust and successful clinical development program, reflects Italfarmaco’s commitment to providing a safe and proven-effective therapy that can have a meaningful impact for people living with DMD,” said Paolo Bettica, MD, PhD, chief medical officer at Italfarmaco Group in a press release.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 98

Drugs Antibody Pharma Companies Development 98

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.

Licensing 70

Licensing Licensing Trials Clinical Trials 70

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home.

Marketing 104

Marketing Drugs Regulation Development 104

pharmaphorum

JULY 1, 2021

Merck and its partners are hoping to have initial data from trials of the bioelectronic device by the end of 2022 , which will then be used to establish a clinical development plan with an eye on getting approvals in major markets like Europe and the US.

Drug Delivery 94

Drug Delivery Pharma Companies Clinical Development Development 94

pharmaphorum

APRIL 28, 2022

Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them. So that is the trick.

Pharma Companies 57

Pharma Companies Branding Development Marketing 57

Pharmaceutical Technology

JUNE 15, 2023

Product management AI in product management can improve every phase of a product, from ideation to development to commercialization. AI helps unlock meaningful questions in the exploration phase, improves predictive models using sophisticated data science techniques and can even inform product marketing.

Pharma R&D 130

Pharma R&D Production Manufacturing Development 130

pharmaphorum

JULY 5, 2021

Parexel has been a champion of the concept for years, but while adoption was fairly slow pre-COVID, it has accelerated at a fast pace since the crisis, aided by the increasing willingness of regulators to accept decentralised trial data in marketing applications.

Clinical Trials 62

Clinical Trials Clinical Trials Trials Regulation 62

pharmaphorum

NOVEMBER 15, 2022

This proved highly beneficial for those pitching products, mechanisms of action, and companies to investors, allowing them to focus on their presentations, instead of competing to cut through the chatter rising from the floor. How healthcare innovators are weathering market conditions. For Müllenbeck, this is an opportunity.

Life Science 96

Life Science Pharma Companies Marketing Production 96

Delveinsight

AUGUST 24, 2020

The launch of the Pipeline therapies, increasing EPI prevalence shall fuel the Exocrine pancreatic insufficiency market size estimated to be approximately USD 1,695.26 However, the main pharmacologic treatment and the mainstay in the Exocrine pancreatic insufficiency market is Pancreatic enzyme replacement therapy (PERT).

Marketing 52

Marketing Production Pharma Companies Containment 52

XTalks

OCTOBER 22, 2020

Pharmaceutical development of novel drugs is a complex and tedious process. The information shared between different multidisciplinary teams is critical to reducing the cost and ultimately accelerating the path of bringing a drug to market.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

DECEMBER 15, 2021

Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen. Previously, Anthony served as the Global Head of Patient Insights, Solutions and Outcomes at Sanofi.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

Delveinsight

AUGUST 4, 2021

Several therapies have been approved in the Epilepsy Market. The Epilepsy Treatment Market is dominated by antiepileptic medications (AEDs), which is the early treatment choice for almost all patients with multiple seizures. and Neurimmune are actively working in the Alzheimer’s Therapeutics Market. Parkinson’s Disease.

Marketing 98

Marketing Genetics Development Clinical Development 98

Drug Discovery World

MARCH 29, 2023

Regulatory data protection (RDP) period RDP refers to the time when generic drug makers cannot refer to an innovator drug’s data to obtain a marketing authorisation 2. According to EFPIA, RDP protects an innovator’s investment by granting a limited period of exclusivity on the data it generated, starting from marketing authorisation 4.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

Drug Discovery World

OCTOBER 4, 2022

Erhardt adds that despite the ever-increasing number of people with AD, there has been an erosion of market value (from $4.2 Several of the large pharma companies have recently re-entered the dementia field. is President, Head of Development & Operations of Oligomerix. Focused on opportunity . William Erhardt, M.D.,

Development 52

Development In-Vivo Compound Screening Clinical Development 52

pharmaphorum

DECEMBER 23, 2020

The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade. Biogen and Denali will co-market the lead LRRK2 product in the US and China, and Biogen will commercialise in all other markets.

Marketing 94

Marketing Gene Silencing Gene Drugs 94

pharmaphorum

DECEMBER 2, 2020

Their follow-up to penicillin, Terramycin, first marketed in 1950, was both their first proprietary drug, and the first for which the company used sales reps, their soon to be formidable force of salesmen starting with just eight members. Antibiotics marked the transition to the modern Pfizer.

Sales 127

Sales Production Drugs Marketing 127

pharmaphorum

JUNE 24, 2022

It’s an approach that Happify has already taken with partner Almirall, developing an app called Claro that can support mental health in people with the skin disorder psoriasis and was recently launched in Europe.

Pharma Companies 40

Pharma Companies Development Clinical Development Marketing 40

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

NOVEMBER 23, 2021

GSK gets worldwide rights to the potentially first-in-class drug, with the exception of China, and will be wholly responsible in its markets for clinical development and commercialisation. Arrowhead said the partnering process for ARO-HSD was competitive and GSK was one of several suitors for the drug.

Sales 52

Sales Drugs Trials RNA 52

pharmaphorum

FEBRUARY 18, 2021

After a year in which the need for digital transformation in pharma reached white heat levels, the sector mustn’t cool off in 2021 and revert to business-as-usual. A return to normal is the longed for goal for many of us, but pharma companies must decide what their future normal should look like. years and $2.5

Medicine 109

Medicine Pharma Companies Clinical Trials Clinical Trials 109

pharmaphorum

MAY 14, 2021

In an interview with pharmaphorum’s news editor Richard Staines, chief operating officer Arnout Ploos van Amstel revealed how the biotech and its “mystery CEO” managed to swoop for the drug ahead of big pharma rivals. It’s extremely possible a pharma company may want to partner and it can have many forms.

Licensing 65

Licensing Licensing Drugs Marketing 65

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. The NIHR is also embedded in the NHS, perhaps the most trusted institution in the UK.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

Drug Discovery World

OCTOBER 16, 2023

Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

SEPTEMBER 29, 2020

As a result of this shift in drug development, a highly concentrated overlay in product modalities and mechanisms of action has crowded the oncology pipeline across a very broad range of hematological and solid tumour indications. Case Study: From Technology Agreement to co-development and co-commercialisation partnership.

Research 132

Research Gene Editing Gene Development 132

pharmaphorum

APRIL 7, 2021

Under the leadership of CEO Jan van de Winkel it has gone from financially precarious position following the stock market crash in the late noughties, to the darling of the Nasdaq with a US IPO of more than $500 million in 2019. Richard Staines is the news editor for pharmaphorum and has been covering the pharma industry since 2010.

Antibody 90

Antibody Life Science Development Regulation 90

Drug Discovery World

OCTOBER 4, 2022

There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . With 3,633 advanced therapeutical medicinal products (ATMPs) currently in some form of clinical or pre- clinical development, the sector shows no signs of slowing down.

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

Delveinsight

JULY 29, 2020

The situation worldwide was so serious that the whole nation was put under lockdown from 25 March 2020, all the flights were cancelled, public transportation was ceased, companies were shut and markets were closed down. Based in Ahmedabad, Zydus Cadila is one of the top most pharma companies in the Indian pharmaceutical industry.

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

Pharma Marketing Network

JUNE 8, 2020

Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. My background for decades now is in the pharma marketing and branding space, working with all sorts of pharma products, devices, diagnostics. Do you connect patients with the clinical trial folks? Bob (83Bar): Great to be here.

Doctors 40

Doctors Doctor Clinical Trials Clinical Trials 40

pharmaphorum

OCTOBER 26, 2022

Every pharma company developing treatments for new diseases is contributing to some degree to better global health. We design our clinical development strategy and the trials with this aim in mind.”. But rare diseases are a particularly important and challenging focus area. “We About Chiesi Group.

Development 96

Development Trials Marketing Life Science 96